A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer
-
Lazar, Vladimir (Gustave-Roussy Cancer Center (France))
;
Rubin, Eitan (Ben-Gurion University of the Negev (Israel)) ;
Depil, Stephane (Leon Berard Cancer Center (France)) ;
Pawitan, Yudi (Karolinska Institutet (Estocolm, Suècia)) ;
Martini, Jean-François (Pfizer Oncology Research (USA)) ;
Gomez-Navarro, Jesus (Takeda Pharmaceuticals International Co.(USA)) ;
Yver, Antoine (AstraZeneca Pharmaceuticals LP (USA)) ;
Kan, Zhengyin (Pfizer Oncology Research (USA)) ;
Dry, Jonathan R. (AstraZeneca Pharmaceuticals LP (USA)) ;
Kehren, Jeanne (Sanofi (France)) ;
Validire, Pierre (Institut Mutualiste Montsouris (France)) ;
Rodón Ahnert, Jordi (Vall d'Hebron Institut d'Oncologia) ;
Vielh, Philippe (Gustave-Roussy Cancer Center (France)) ;
Ducreux, Michel (Gustave-Roussy Cancer Center (France)) ;
Galbraith, Susan (AstraZeneca Pharmaceuticals LP (USA)) ;
Lehnert, Manfred (Takeda Pharmaceuticals International Co. (USA)) ;
Onn, Amir (Chaim Sheba Medical Center (Israel)) ;
Berger, Raanan (Chaim Sheba Medical Center (Israel)) ;
Pierotti, Marco A. (Fondazione IRCCS Istituto Nazionale dei Tumori (Italy)) ;
Porgador, Angel (Ben-Gurion University of the Negev (Israel)) ;
Pramesh, C. S. (Tata Memorial Centre (India)) ;
Ye, Ding-wei (Fudan University Shanghai Cancer Center (China)) ;
Carvalho, Andre L. (Barretos Cancer Hospital. Fundacao Pio XII (Brazil)) ;
Batist, Gerald (Jewish General Hospita. Segal Cancer Centre (Canada)) ;
Le Chevalier, Thierry (Gustave-Roussy Cancer Center (France)) ;
Morice, Philippe (Gustave-Roussy Cancer Center (France)) ;
Besse, Benjamin (Gustave-Roussy Cancer Center (France)) ;
Vassal, Gilles (Gustave-Roussy Cancer Center (France)) ;
Mortlock, Andrew (AstraZeneca Pharmaceuticals LP (USA)) ;
Hansson, Johan (Karolinska Institutet (Estocolm, Suècia)) ;
Berindan Neagoe, Ioana (Universitatea de Medicină şi Farmacie Iuliu Haţieganu Cluj-Napoca (Romania)) ;
Dann, Robert (General Electric Healthcare (USA)) ;
Haspel, Joel (Oracle Corporation (UK)) ;
Irimie, Alexandru (Universitatea de Medicină şi Farmacie Iuliu Haţieganu Cluj-Napoca (Romania)) ;
Laderman, Steve (Agilent Technologies (USA)) ;
Nechushtan, Hovav (Hadassah Hebrew University Medical Center (Israel)) ;
Al Omari, Amal S. (King Hussein Cancer Center (Jordan)) ;
Haywood, Trent (Blue Cross Blue Shield Association (USA)) ;
Bresson, Catherine (WIN Consortium (France)) ;
Soo, Khee Chee (National Cancer Centre (Singapore)) ;
Osman, Iman (New York University Langone Medical Center (USA)) ;
Mata, Hilario (MD Anderson Cancer Center (USA)) ;
Lee, Jack J. (MD Anderson Cancer Center (USA)) ;
Jhaveri, Komal (New York University Langone Medical Center (USA)) ;
Meurice, Guillaume (Gustave-Roussy Cancer Center (France)) ;
Palmer, Gary (Foundation Medicine Inc. (USA)) ;
Lacroix, Ludovic (Gustave-Roussy Cancer Center (France)) ;
Koscielny, Serge (Gustave-Roussy Cancer Center (France)) ;
Eterovic, Karina Agda (MD Anderson Cancer Center (USA)) ;
Blay, Jean-Yves (Leon Berard Cancer Center (France)) ;
Buller, Richard (Pfizer Oncology Research (USA)) ;
Eggermont, Alexander (Gustave-Roussy Cancer Center (France)) ;
Schilsky, Richard L. (American Society of Clinical Oncology (USA)) ;
Mendelsohn, John (MD Anderson Cancer Center (USA)) ;
Soria, Jean-Charles (Gustave-Roussy Cancer Center (France)) ;
Rothenberg, Mace (Pfizer Oncology Research (USA)) ;
Scoazec, Jean-Yves (Gustave-Roussy Cancer Center (France)) ;
Ki Hong, Waun (MD Anderson Cancer Center (USA)) ;
Kurzrock, Razelle (Moores Cancer Center (USA)) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
